Cidara Therapeutics (CDTX) News Today $55.32 +4.78 (+9.46%) Closing price 04:00 PM EasternExtended Trading$55.38 +0.06 (+0.11%) As of 04:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CDTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Cidara Therapeutics (NASDAQ:CDTX) Trading 5.9% Higher - Still a Buy?2 hours ago | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Sees Strong Trading Volume - Here's WhyJuly 9, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Shares Gap Down - Here's What HappenedJuly 8, 2025 | marketbeat.comSegal Trials Contributes to Breakthrough Flu Prevention Study Led by Cidara TherapeuticsJuly 7, 2025 | businesswire.comWarner Bros., Cidara, LENZ Therapeutics, and More Stocks See Action From Activist InvestorsJuly 3, 2025 | msn.comCidara Therapeutics (NASDAQ:CDTX) Sees Strong Trading Volume - What's Next?July 2, 2025 | marketbeat.comCidara Therapeutics Added to Russell 2000 and Russell 3000 Indexes Recognizing Corporate Progress - NasdaqJuly 2, 2025 | nasdaq.comCidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)July 1, 2025 | globenewswire.comInsider Buying: Cidara Therapeutics, Inc. (NASDAQ:CDTX) Director Buys 2,272,727 Shares of StockJuly 1, 2025 | insidertrades.comRa Capital Management, L.P. Purchases 2,272,727 Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX) StockJune 30, 2025 | marketbeat.comBiotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains (CDTX)With major rallies and analyst backing, Nektar, Cidara, and GeneDx are drawing interest; will these biopharma firms maintain their growth trajectories?June 30, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Stock Price Down 5% - Should You Sell?June 30, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Given "Market Outperform" Rating at JMP SecuritiesJune 30, 2025 | marketbeat.comCidara Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® IndexesJune 30, 2025 | globenewswire.comCidara Therapeutics Inc (CDTX) - Investing.com UKJune 29, 2025 | uk.investing.comCidara Therapeutics, Inc. (CDTX) - Yahoo FinanceJune 28, 2025 | finance.yahoo.comCidara Therapeutics Closes Public Offering of 9.1 Million Shares, Raising $402.5 Million - NasdaqJune 27, 2025 | nasdaq.comCidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesJune 26, 2025 | uk.finance.yahoo.comCidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional SharesJune 26, 2025 | globenewswire.comCidara Therapeutics (NASDAQ:CDTX) Sees Strong Trading Volume - Still a Buy?June 26, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Shares Gap Down - Time to Sell?June 25, 2025 | marketbeat.comCidara Therapeutics Advances CD388 To Phase 3, Reiterate BuyJune 25, 2025 | seekingalpha.comCidara Therapeutics prices upsized $350 milion stock offering at $44June 25, 2025 | msn.comCidara Announces Pricing of Upsized Public Offering of Common StockJune 24, 2025 | globenewswire.comCidara reports outcomes from trial of CD388 for preventing seasonal influenzaJune 24, 2025 | msn.comCDTX Stock Quote Price and Forecast | CNNJune 24, 2025 | cnn.comRoyal Bank Of Canada Forecasts Strong Price Appreciation for Cidara Therapeutics (NASDAQ:CDTX) StockJune 24, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Reaches New 1-Year High After Analyst UpgradeJune 24, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Price Target Raised to $68.00 at GuggenheimJune 24, 2025 | marketbeat.comCidara Therapeutics Inc.June 23, 2025 | wsj.comCidara Therapeutics stock falls after proposed public offering announcementJune 23, 2025 | uk.investing.comCidara Therapeutics’ Market Cap Doubles After Investigational Drug Shows Positive Results In Preventing Influenza In Mid-stage TrialJune 23, 2025 | msn.comCidara Announces Proposed Public Offering of Common StockJune 23, 2025 | globenewswire.comCidara Shares Soar Premarket After Positive Influenza Trial ResultsJune 23, 2025 | marketwatch.comCidara Therapeutics stock rockets after positive flu prevention trial resultsJune 23, 2025 | in.investing.comCidara Launches 93% As A Universal Flu Shot Becomes A Closer RealityJune 23, 2025 | msn.comCidara Therapeutics (NASDAQ:CDTX) Shares Gap Up Following Analyst UpgradeJune 23, 2025 | marketbeat.comCidara Therapeutics' (CDTX) Strong-Buy Rating Reaffirmed at WBB SecuritiesJune 23, 2025 | marketbeat.comNeedham & Company LLC Issues Positive Forecast for Cidara Therapeutics (NASDAQ:CDTX) Stock PriceJune 23, 2025 | marketbeat.comWhy Is Cidara Therapeutics Stock Trading Higher On Monday?June 23, 2025 | benzinga.comTraders Buy High Volume of Put Options on Cidara Therapeutics (NASDAQ:CDTX)June 23, 2025 | marketbeat.comCidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal InfluenzaJune 23, 2025 | globenewswire.comWhat is HC Wainwright's Estimate for CDTX Q2 Earnings?June 23, 2025 | marketbeat.comCidara Therapeutics, Inc. (NASDAQ:CDTX) Given Consensus Recommendation of "Buy" by BrokeragesJune 21, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Receives Buy Rating from HC WainwrightJune 18, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Stock Crosses Above Fifty Day Moving Average - Here's WhyJune 18, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Given Overweight Rating at Cantor FitzgeraldJune 10, 2025 | marketbeat.comMillennium Management LLC Raises Stock Holdings in Cidara Therapeutics, Inc. (NASDAQ:CDTX)June 6, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Receives "Market Outperform" Rating from JMP SecuritiesJune 2, 2025 | marketbeat.com12,714 Shares in Cidara Therapeutics, Inc. (NASDAQ:CDTX) Purchased by Jane Street Group LLCJune 2, 2025 | marketbeat.com Get Cidara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDTX and its competitors with MarketBeat's FREE daily newsletter. Email Address CDTX Media Mentions By Week CDTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CDTX News Sentiment▼1.081.01▲Average Medical News Sentiment CDTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CDTX Articles This Week▼33▲CDTX Articles Average Week Get Cidara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PTC Therapeutics News Today Ultragenyx Pharmaceutical News Today Ascentage Pharma Group International News Today Merus News Today Arcellx News Today SpringWorks Therapeutics News Today Avidity Biosciences News Today ACADIA Pharmaceuticals News Today Scholar Rock News Today Viking Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CDTX) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cidara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cidara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
